Not applicableStudy completedNCT02647112What this trial is testingUtility of Bladder EpiCheck for Detection of Recurrent Urothelial CarcinomaWho this might be right forBladder Cancer Nucleix Ltd. 1,050
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643519What this trial is testingNeoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial CarcinomaWho this might be right forUrothelial Carcinoma (UC) University of Florida 39
Not applicableActive Not RecruitingNCT03291028What this trial is testingAnalysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial CarcinomaWho this might be right forRenal Cell CarcinomaUrothelial CarcinomaBladder Cancer+2 more Fox Chase Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT03747419What this trial is testingAvelumab and Radiation in Muscle-Invasive Bladder CancerWho this might be right forBladder CancerMuscle Invasive Bladder Cancer Dana-Farber Cancer Institute 14
Testing effectiveness (Phase 2)Study completedNCT01688999What this trial is testingCabozantinib for Advanced Urothelial CancerWho this might be right forUrothelial CarcinomaUrethral NeoplasmsUrinary Bladder Neoplasms+1 more National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05544552What this trial is testingSafety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene AlterationsWho this might be right forLocally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaSolid Tumor+11 more Tyra Biosciences, Inc 310
Not applicableEnded earlyNCT02202044What this trial is testingSequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral ResectionWho this might be right forBladder Carcinoma University of Colorado, Denver 13
Not applicableLooking for participantsNCT07602010What this trial is testingComparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer StagingWho this might be right forBladder CancerUrothelial Carcinoma (UC)Muscle Invasive Bladder Cancer (MIBC)+1 more Oslo University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00006351What this trial is testingSCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07625527What this trial is testingIs Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?Who this might be right forBladder (Urothelial, Transitional Cell) CancerNon Muscle Invasive Bladder Cancer Tianjin Medical University Second Hospital 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07822373What this trial is testingStudy Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial CancerWho this might be right forMuscle-invasive Bladder Urothelial Carcinoma University of Utah 25
Not applicableStudy completedNCT05946369What this trial is testingNeutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder CancerWho this might be right forUrinary Bladder CancerUrinary Bladder NeoplasmBCG+2 more Ain Shams University 96
Testing effectiveness (Phase 2)UnknownNCT03263039What this trial is testingBiomarkers in Urothelial Cancer Patients Treated With PembrolizumabWho this might be right forTransitional Cell Carcinoma of the BladderBiomarkers Erasmus Medical Center 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07332351What this trial is testingNeoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA TrialWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8 University of Washington 33
Large-scale testing (Phase 3)Study completedNCT00003701What this trial is testingCombination Chemotherapy in Treating Patients With Bladder CancerWho this might be right forBladder CancerUrethral Cancer Eastern Cooperative Oncology Group 490
Testing effectiveness (Phase 2)Ended earlyNCT05563272What this trial is testing89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsWho this might be right forCervical CancerColorectal CancerEsophageal Cancer+16 more Telix Pharmaceuticals (Innovations) Pty Ltd 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT00756639What this trial is testingProphylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the UrotheliumWho this might be right forBladder Cancer M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00380029What this trial is testingErlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder CancerWho this might be right forBladder Cancer UNC Lineberger Comprehensive Cancer Center 27
Early research (Phase 1)Study completedNCT03053635What this trial is testingIntravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) PatientsWho this might be right forNon-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Theralase® Technologies Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT00933374What this trial is testingTrial to Evaluate Paclitaxel Plus RAD001 in Urothelial CarcinomaWho this might be right forBladder Cancer Heinrich-Heine University, Duesseldorf 28